Assay Detail
Functional
CHEMBL2168450
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Cytotoxicity against human LNZ308 cells after 72 hrs by MTT assay
11
Total Activities
11
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Homo sapiens |
| Cell Type | LNZ308 |
| Confidence | 1 — Organism |
| Curated By | Autocuration |
Publication
Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 11 | 5.11 | 5.68 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL448434 | — | — | 1 | 5.68 |
| CHEMBL112210 | — | — | 1 | 5.36 |
| CHEMBL479464 | — | — | 1 | 5.33 |
| CHEMBL324162 | — | — | 1 | 5.28 |
| CHEMBL393220 | ATORVASTATIN CALCIUM | 4.0 | 1 | 5.13 |
| CHEMBL2164235 | — | — | 1 | 4.90 |
| CHEMBL481608 | — | — | 1 | 4.84 |
| CHEMBL2164234 | — | — | 1 | 4.82 |
| CHEMBL2164236 | — | — | 1 | 4.63 |
| CHEMBL2164238 | — | — | 1 | - |
| CHEMBL2164237 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL448434 | — | IC50 | = | 2100.0 | nM | 5.68 |
| CHEMBL112210 | — | IC50 | = | 4400.0 | nM | 5.36 |
| CHEMBL479464 | — | IC50 | = | 4700.0 | nM | 5.33 |
| CHEMBL324162 | — | IC50 | = | 5260.0 | nM | 5.28 |
| CHEMBL393220 | ATORVASTATIN CALCIUM | IC50 | = | 7440.0 | nM | 5.13 |
| CHEMBL2164235 | — | IC50 | = | 12600.0 | nM | 4.90 |
| CHEMBL481608 | — | IC50 | = | 14400.0 | nM | 4.84 |
| CHEMBL2164234 | — | IC50 | = | 15300.0 | nM | 4.82 |
| CHEMBL2164236 | — | IC50 | = | 23200.0 | nM | 4.63 |
| CHEMBL2164238 | — | IC50 | > | 30000.0 | nM | - |
| CHEMBL2164237 | — | IC50 | > | 30000.0 | nM | - |